247 results on '"Chang, Myung Hee"'
Search Results
2. A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma
3. High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma
4. Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
5. A Study on Attitudes and Acceptance of Port Digital Transformation
6. Clinical Features and Survival of Patients With Follicular Lymphoma in Korea
7. Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis
8. A prospective study of preemptive tenofovir disoproxil fumarate therapy in HBsAg-positive diffuse large B cell lymphoma patients receiving R-CHOP
9. Comprehensive Analysis of Iron Deficiency Anemia and Its Related Disorders in Premenopausal Women Based on a Propensity Score Matching Case Control Study Using National Health Insurance Service Database in Korea
10. A Study on the Priority of Sustainability Areas and Indicators of Domestic Smart Ports
11. Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma
12. Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure
13. Somatic Mutations in Myeloid Transcription Factors and in Activated Signaling Pathway, but Not in Epigenetic Modifier Pathway, Predict the Risk of Treatment Failure and Progression to Advanced Phase in Chronic Myeloid Leukemia
14. The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy
15. Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
16. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin
17. Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q
18. The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer
19. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
20. Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics
21. A Study on the Priority Evaluation of the Success Factors for Digital Transformation in Maritime Transport Sector
22. Eosinophilia in Patients with End Stage Renal Disease Undergoing Hemodialysis
23. Single-Cell Proteogenomic Sequencing Allows Early Detection of Relapse Clone with CN-LOH at FLT3-ITD Locus from Initial Diagnosis in AML
24. Detection of SET-NUP214 rearrangement using multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) in acute leukemias: a case report and literature review on a Korean case series
25. Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
26. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
27. Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
28. Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer
29. A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
30. Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
31. Rituximab-induced acute thrombocytopenia: a case report and review of the literature
32. Risk of opioid-related aberrant behaviors predicted by Opioid Risk Tool among cancer patients receiving opioid analgesics
33. Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
34. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer
35. Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors
36. A Rare Splicing Mutation in the PROS1 Gene of a Korean Patient with Type I Hereditary Protein S Deficiency
37. The Causal Relationship Test between Marine Business Cycle and Shipping Market Using Heterogeneous Mixed Panel Framework
38. Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy
39. Interdigitating dendritic cell sarcoma of the tonsil
40. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer
41. Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
42. A Study on the Innovation Resistance Caused by Blockchain to the Shipping and Port Industry
43. Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)
44. Myeloproliferative Neoplasm in Newly Diagnosed Acute Ischemic Stroke Patients
45. High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
46. A Study on the Intention to Use Big Data Based on the Technology Organization Environment and Innovation Diffusion Theory in Shipping and Port Organization
47. Effects of Cold Agglutinin on the Accuracy of Complete Blood Count Results and Optimal Sample Pretreatment Protocols for Eliminating Such Effects
48. A novel type of +2-base pair frameshift CALR mutation in a patient with myeloproliferative neoplasm
49. Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms
50. Effects of Nutrition Education and Exercise Program on Obesity Index and Behavioral Modification in Moderate Obese Women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.